Dr. Billy Hamilton Cordon, MD

Dr. Cordon practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Cordon's NPI, 1447494901, was assigned on April 28, 2009. Dr. Cordon graduated from UCSF School of Medicine in 2009. Dr. Cordon holds Florida license ME127951.

Dr. Cordon's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Cordon's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. The medical group on file is Mount Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cordon practices. Vendor and product names are available with a free account.

Urology is Dr. Cordon's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Cordon is board certified in urology by the American Board of Urology. Dmand AI has Dr. Cordon's licenses on file in 3 states: Florida, New York and Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Cordon treats.

CMS data shows 690 Medicare services from Dr. Cordon across 11 procedure codes in 2024, for 316 Medicare patients. Medicare paid $58,042 for them.

CMS counts 316 Medicare patients who saw Dr. Cordon in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cordon's median patient age at 69, with 13% women.

In 2024, Dr. Cordon wrote 976 Medicare Part D claims for 329 patients. 79% of them were for generic drugs. CMS names the drug for 843 of them, across 20 drugs with 11 or more claims each, at $386,218 in total drug cost. In 2023, CMS named 735 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Cordon for performance year 2024, reported as part of a group. Dr. Cordon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cordon as offering telehealth. CMS counts 16 procedures of prostate resection by Dr. Cordon, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 41 papers to Dr. Cordon, published from 2014 to 2024. 2016 was the busiest year, with 7. The most frequent topics are Urethra, Urethral Stricture and Urologic Surgical Procedures, Male. Dr. Cordon has published most often in Urology. Dr. Cordon's most frequent co-authors are Allen Frank Morey, MD, Matthias Dominikus Hofer, MD and Boyd Ramsey Viers, MD.

CMS Open Payments shows 493 general payments to Dr. Cordon from 51 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 36% of the total. Coloplast Corp paid the most, $66,926.

Dmand AI lists 8 awards for Dr. Cordon, most recently Fellow in Urologic Reconstruction, Trauma, and Prosthetics in 2016. Dr. Cordon serves on SMSNA - Young Clinicians Committee.

Dr. Cordon graduated from UCSF School of Medicine in 2009. Dr. Cordon is a member of ACS, AUA, International Society for Sexual Medicine, Sexual Medicine Society of North America and Society of Genitourinary Reconstructive Surgeons.

Dr. Cordon is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.